MCL coexpression mm9:296
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0042892 | chloramphenicol transport | 0.00701254588286857 |
GO:0042891 | antibiotic transport | 0.00701254588286857 |
GO:0043244 | regulation of protein complex disassembly | 0.00701254588286857 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 0.00841459401106075 |
GO:0002752 | cell surface pattern recognition receptor signaling pathway | 0.00841459401106075 |
GO:0002238 | response to molecule of fungal origin | 0.0105176662244004 |
GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 0.0120195313783155 |
GO:0002224 | toll-like receptor signaling pathway | 0.0131456421358788 |
GO:0002221 | pattern recognition receptor signaling pathway | 0.0140181770504761 |
GO:0032760 | positive regulation of tumor necrosis factor production | 0.0140181770504761 |
GO:0002218 | activation of innate immune response | 0.0140181770504761 |
GO:0002758 | innate immune response-activating signal transduction | 0.0140181770504761 |
GO:0032680 | regulation of tumor necrosis factor production | 0.0140181770504761 |
GO:0045088 | regulation of innate immune response | 0.0140181770504761 |
GO:0045089 | positive regulation of innate immune response | 0.0140181770504761 |
GO:0009620 | response to fungus | 0.0151838620381715 |
GO:0043241 | protein complex disassembly | 0.0151838620381715 |
GO:0015893 | drug transport | 0.0151838620381715 |
GO:0032984 | macromolecular complex disassembly | 0.0154903787390998 |
GO:0032640 | tumor necrosis factor production | 0.0157661285899398 |
GO:0006915 | apoptosis | 0.0177806043039439 |
GO:0001819 | positive regulation of cytokine production | 0.0177806043039439 |
GO:0012501 | programmed cell death | 0.0177806043039439 |
GO:0008219 | cell death | 0.0177806043039439 |
GO:0016265 | death | 0.0177806043039439 |
GO:0022411 | cellular component disassembly | 0.0177806043039439 |
GO:0001817 | regulation of cytokine production | 0.0225045307870591 |
GO:0042493 | response to drug | 0.0225045307870591 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 0.0231745390088081 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 0.0237995731722582 |
GO:0002757 | immune response-activating signal transduction | 0.024383985638227 |
GO:0002764 | immune response-regulating signal transduction | 0.0249315847224307 |
GO:0019221 | cytokine and chemokine mediated signaling pathway | 0.0286185847577295 |
GO:0048468 | cell development | 0.039830640220822 |
GO:0002253 | activation of immune response | 0.0460903485865604 |
GO:0005524 | ATP binding | 0.0462014597936259 |
GO:0032559 | adenyl ribonucleotide binding | 0.0462014597936259 |
GO:0045087 | innate immune response | 0.048186354519928 |
GO:0030554 | adenyl nucleotide binding | 0.048186354519928 |
GO:0050778 | positive regulation of immune response | 0.0493229335703659 |
GO:0002684 | positive regulation of immune system process | 0.0493229335703659 |
GO:0001816 | cytokine production | 0.0493229335703659 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
common myeloid progenitor | 8.41e-13 | 19 |
hematopoietic cell | 3.13e-10 | 32 |
hematopoietic oligopotent progenitor cell | 3.13e-10 | 32 |
hematopoietic stem cell | 3.13e-10 | 32 |
angioblastic mesenchymal cell | 3.13e-10 | 32 |
hematopoietic multipotent progenitor cell | 3.13e-10 | 32 |
myeloid cell | 2.32e-08 | 16 |
connective tissue cell | 4.42e-08 | 46 |
mesenchymal cell | 4.42e-08 | 46 |
granulocyte monocyte progenitor cell | 3.26e-07 | 7 |
Ontology term | p-value | n |
---|---|---|
bone marrow | 2.08e-10 | 16 |
musculoskeletal system | 7.60e-09 | 32 |
bone element | 1.76e-08 | 22 |
skeletal element | 1.76e-08 | 22 |
skeletal system | 1.76e-08 | 22 |
connective tissue | 4.42e-08 | 46 |
hemolymphoid system | 7.32e-07 | 48 |
immune system | 7.32e-07 | 48 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 8.02e-07 | 3 |
muscle cancer | 8.02e-07 | 3 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |